PanTera aims to secure the large-scale production of actinium-225 (Ac-225), targeting its use in radiopharmaceuticals for personalized cancer treatment. The company focuses on improving the accessibility of innovative cancer therapies based on Ac-225.

PanTera

Sven Van den Berghe

Founder & CEO

Samy Bertrand

Christophe Malice

Europe Early Stage Companies With Fewer Than 50 Employees

Europe Pharmaceutical Companies

European Union (EU) Pharmaceutical Companies

Companies With Fewer Than 1000 Employees (Top 10K)

PanTera focuses on the large-scale production of actinium-225, a promising radioisotope for targeted cancer therapies. The company aims to improve accessibility to personalized nuclear medicine treatments while ensuring sustainability through the recycling of materials in their production process.

EQT Life Sciences

Series A - PanTera

Debt Financing - PanTera

Antwerpen

Belgium

Europe

European VC Funding Drops To Lowest Quarter In 4 Years, Despite Uptick For German Startups

The Week’s 10 Biggest Funding Rounds: Another Big Week For Biotech And AI

Germany

United Kingdom

Bangladesh

Asia

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Nov 13, 2024 12:23 AM	c8a53ff7
public peers	general	Sep 27, 2024 5:25 PM	ff4bb7e1
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Nov 12, 2024 11:01 PM	f09be548
company summary	general
signals	general	Nov 12, 2024 8:36 AM	209252fc
crunchbase trigger	general	Nov 12, 2024 8:36 AM	89c950e4
crunchbase profile	general	Nov 12, 2024 8:38 AM	bc9ac55f
li profile	general
translate crunchbase fundingrounds	general	Nov 12, 2024 8:39 AM	79179d27
peers	general	Nov 12, 2024 8:36 AM	fc835a00
news basic	general	Nov 12, 2024 8:36 AM	5fec3d2d
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:PANTERA-LIFE

PanTera